Navigation Links
Covance Increases Early Clinical Footprint in Europe with Acquisition of Swiss-Based Early Clinical Development Site
Date:3/13/2009

PRINCETON, N.J., March 13 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD) announced today that it is expanding its clinical pharmacology footprint in Europe with the acquisition of Swiss Pharma Contract, a 50-bed clinical research company based in Basel, Switzerland.

"Our clients' need for complex, high-science clinical pharmacology studies that can help them make decisions faster is growing," said Joe Herring, Covance chief executive officer. "This acquisition significantly increases Covance's early clinical development footprint in Europe and gives our clients access to special patient populations for Phase I/IIa clinical studies. Covance's early clinical development offerings are well-positioned to provide our clients with the knowledge critical to enhancing downstream success rates."

Swiss Pharma Contract is an experienced, high-quality provider of clinical research services to the pharmaceutical, biotechnology, and medical-device industries, working with 10 of the top 20 pharmaceutical companies. Swiss Pharma Contract has conducted more than 200 complex clinical trials since 2002, with roughly a third of them being first-in-human studies. The Basel site also has substantial expertise in radiolabeled and proof-of-concept studies, a wealth of experience in specialty therapeutic areas, and access to a large and active volunteer database.

The business includes a modern, well-equipped clinical pharmacology facility that will increase Covance's global capacity to approximately 550 beds in the United States and Europe. The company's talented staff includes nine physicians as well as other medical staff experienced in complex clinical trials. All Swiss Pharma Contract employees will be offered employment at Covance.

Covance, with headquarters in Princeton, New Jersey, is one of the world's largest
'/>"/>

SOURCE Covance Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Covance Purchases Equity Stake in Caprion Proteomics
2. Covance and Lilly Finalize 10-Year, $1.6 Billion Strategic R&D Collaboration
3. Covance Decides to Pursue Its Original Preclinical Strategy in China
4. Covance and WuXi PharmaTech to Form a Joint Venture to Provide World-Class Preclinical Services in China
5. Covance to Present at The R.W. Baird 2008 Growth Stock Conference
6. Covance to Present at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
7. Covance Reports Full-Year 2007 Revenue Growth Of 15.4% and Seventh Consecutive Year of EPS Growth in Excess of 20%
8. Covance Inc. Invites You to Join the Webcast of Its Third Quarter 2007 Financial Results Conference Call
9. Simbionix Increases Product Offerings for OB/GYN Physicians
10. R&D Spending by U.S. Biopharmaceutical Companies Increases 3 Percent in 2008
11. Despite Economic Woes, Physician Compensation Increases

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...ORK, Dec. 2 Reportlinker.com annou...e in its catalogue: ,, Neurostimulation - A Gl...inker.com/p0164232/Neurostimulation---A-Global-Mar...ation market stands enthused by the growing base o...related diseases such as, Parkinson,s, and Alzheim...
(Date:12/2/2009)..., Dec. 2 The world,s first concept...ology, a breakthrough alternative to replace a pet...e of synthetic rubber with renewable biomass, made...e tire will be on display at a lounge in the commo...irport throughout December 21, while the other tir...
(Date:12/2/2009)...AD, The Netherlands, December 2 Pe...ogy company focusing on protein mimicking,technolo... announced that it,has appointed Wim E.M. Mol, Ph....Mol will be responsible for all of Pepscans corpor...egic direction of the company. He brings to,Pepsca...
(Date:12/2/2009)...ON, Va., Dec. 2 /PRNewswire-Asia-FirstCall/ -- Eme...) (OTC Bulletin Board: EMDY), a leading,producer a...ilk powder and,soybean products in China, today an...pring issue of US Food & Drink Executive, a qu... executives in the food and beverage industry. ,...
Breaking Biology Technology:Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3Dutch Biotech Company Pepscan Appoints New CEO 2Emerald Dairy To Be Featured in Spring Issue of US Food and Drink Executive 2
...Wisconsin governor are playing a game of one- upsm... Mark Green ,s turn to up the ante after Gov. Jim...the state,s minimum markup law for ethanol. , ,Gre... for a comprehensive repeal of the minimum markup,...al the controversial law. Instead, he called on th...
...rge Healthcare company producing imaging software... Spanish , a Spanish language version of the compa...005, Workstation is a downloadable radiology softw...ion, and CD burning of digital medical images. Thi... and healthcare providers transition from film to ...
...ic development efforts here are taking shape with ...kers. , ,The state is giving Wisconsin Indianhead...th $152,175 to work with local businesses. With th...portunities to improve the skills of their workers...y management, and computers. , , Gov. Jim Doyle s...
Other Biology Technology:Green doesnt up the ante on markup law 2Superior receives funds for technical training 2
(Date:12/3/2009)...the U.S. Department of Energy,s (DOE) Brookhaven N...dian Institute of Science has made a major step in...formation in DNA that is necessary to carry out im...hed in the December 1, 2009 edition of Nature Str...roteins responsible for interacting at specific si...
(Date:12/2/2009)...engthen the evidence that people who smoke cigaret...isk for developing colorectal cancer, even after a...es one more reason not to smoke, or to quit as soo..., M.D., M.S., vice president emeritus, epidemiolog... Society. "Colorectal cancer should be added to th...
(Date:12/2/2009)...and smoke for a prolonged period of time and in hi..., even in women who never smoked cigarettes themse...de-stream smoke could increase risk of breast canc..., Ph.D., senior research scientist at the Northern...e no single epidemiologic study can answer the que...
Breaking Biology News(10 mins):Grooving down the helix 2Grooving down the helix 3Cigarette smoking increases colorectal cancer risk 2Exposure to secondhand cigarette smoke over a lifetime increased breast cancer risk later in life 2Japanese Cancer Patients Will Have Access to Compensator Based IMRT with Opening of decimal Inc Office in Tokyo and Hiring of Key Personnel 5999 1Japanese Cancer Patients Will Have Access to Compensator Based IMRT with Opening of decimal Inc Office in Tokyo and Hiring of Key Personnel 5999 2Religion and medicine 3A Sometimes a healing prescription 60718 1Religion and medicine 3A Sometimes a healing prescription 60718 2Genomic research will enable greener cleanup of military explosive test sites 10638 1Genomic research will enable greener cleanup of military explosive test sites 10638 2
... , Restless legs syndrome is a common problem in c...tes and the United Kingdom, according to a new rep...Nearly 2 percent of children aged 8 to 17 are affe...ence moderate to severe symptoms, including sleep ... in the August issue of the journal Pediatrics. , ...
... Researchers from the University of Minnesota Med...apolis VA Medical Center have identified a noninva...seases. And its as simple as staring at a point of...ressful, painless, and objective diagnosis for bra...tiveness of different treatments for these disease...
... BOSTONCarnegie Mellon University chemists have s...ventually help scientists develop drug therapies t... and Alzheimers disease. Using intensive theoretic... researchers have modeled the initial molecular ch...te docks with a receptor on a neuron, which sets i...
Other Biology News:Restless legs syndrome affects nearly 2 percent of US/UK children 2Restless legs syndrome affects nearly 2 percent of US/UK children 3U of MN researchers discover noninvasive diagnostic tool for brain diseases 2Carnegie Mellon scientists investigate initial molecular mechanism that triggers neuronal firing 2
Rabbit Anti-Rat 5-HIAA Polyclonal Antibody, Unconjugated from ImmunoStar, Inc.
NuParaffin Kit from Exalpha Biologicals, Inc.
Anti-hamster Ig HRP detection kit from BD Biosciences Pharmingen
MitoLight® Mitochondrial Apoptosis Detection Kit from Upstate
Biology Products: